Luca Mastorino (L Mastorino)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 66

Top Topics

Atopic Dermatitis

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

Journal of clinical medicine

Dermatologic therapy

International journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Luca Mastorino, Paolo Dapavo, Nicole Macagno, Michela Ortoncelli, Anna Verrone, Elena Stroppiana, Caterina Cariti, Sara Susca, Niccolò Siliquini, Isotta Giunipero di Corteranzo, Pietro Quaglino, Simone Ribero
Clinical characteristics and response to biological therapies for inverse psoriasis: a real-life comparison between the therapeutic effects of anti-IL-23 and anti-IL-17 agents. International journal of dermatology (2024)
Gianluca Avallone, Francesco Cavallo, Annalisa Tancredi, Carlo Alberto Maronese, Martina Bertello, Alessandro Fraghì, Conforti Claudio, Giulia Calabrese, Matteo R Di Nicola, Giorgio A Oddenino, Luigi Gargiulo, Niccolò Gori, Camilla Loi, Paolo Romita, Viviana Piras, Laura Bonzano, Ersilia Tolino, Giovanni Paolino, Maddalena Napolitano, Cataldo Patruno, Eustachio Nettis, Caterina Ferreli, Gabriele Roccuzzo, Luca Marozio, Martina Silvio, Filomena Russo, Luca Bettolini, Rosella Gallo, Santo R Mercuri, Luca Mastorino, Mariateresa Rossi, Iris Zalaudek, Giuseppe Argenziano, Ilaria Trave, Antonio Costanzo, Andrea Chiricozzi, Carlotta Gurioli, Caterina Foti, Concetta Potenza, Silvia M Ferrucci, Anna Balato, Aurora Parodi, Angelo Valerio Marzano, Michela Ortoncelli, Simone Ribero, Pietro Quaglino
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Riccardo Viola, Luca Mastorino, Matteo Megna, Giovanni Damiani, Paolo Gisondi, Giuseppe Argenziano, Ketty Peris, Francesca Prignano, Martina Burlando, Andrea Conti, Francesco Loconsole, Piergiorgio Malagoli, Iris Zalaudek, Sara Cacciapuoti, Francesco Bellinato, Anna Balato, Clara De Simone, Karin Chersi, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort. International journal of dermatology (2024)
Luca Mastorino, Paolo Dapavo, Lorenza Burzi, Francois Rosset, Isotta di Giunipero di Corteranzo, Francesco Leo, Anna Verrone, Elena Stroppiana, Michela Ortoncelli, Simone Ribero, Pietro Quaglino
Drug survival, effectiveness, and safety of brodalumab for moderate-to-severe psoriasis over up to 3 years. International journal of dermatology (2024)
Luca Mastorino, Paolo Dapavo, Lorenza Burzi, Francois Rosset, Isotta Giunipero di Corteranzo, Francesco Leo, Anna Verrone, Elena Stroppiana, Michela Ortoncelli, Simone Ribero, Pietro Quaglino
Drug survival, effectiveness, and safety of brodalumab for moderate-to-severe psoriasis up to 3 years. International journal of dermatology (2024)
Luca Mastorino, Paolo Dapavo, Caterina Cariti, Sara Susca, Niccolò Siliquini, Michela Ortoncelli, Elena Stroppiana, Anna Verrone, Isotta Giunipero di Corteranzo, Francesco Leo, Pietro Quaglino, Simone Ribero
Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience. Journal of personalized medicine 14 (7) (2024)
Nicole Macagno, Luca Mastorino, Niccolò Siliquini, Umberto Santaniello, Federica Gelato, Giovanni Cavaliere, Michela Ortoncelli, Simone Ribero, Pietro Quaglino
Safety of dupilumab in patients with cancer. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Gianluca Avallone, Francesco Cavallo, Annalisa Tancredi, Carlo Alberto Maronese, Martina Bertello, Alessandro Fraghì, Conforti Claudio, Giulia Calabrese, Matteo R Di Nicola, Giorgio A Oddenino, Luigi Gargiulo, Niccolò Gori, Camilla Loi, Paolo Romita, Viviana Piras, Laura Bonzano, Ersilia Tolino, Giovanni Paolino, Maddalena Napolitano, Cataldo Patruno, Eustachio Nettis, Caterina Ferreli, Gabriele Roccuzzo, Luca Marozio, Martina Silvio, Filomena Russo, Luca Bettolini, Rosella Gallo, Santo R Mercuri, Luca Mastorino, Mariateresa Rossi, Iris Zalaudek, Giuseppe Argenziano, Ilaria Trave, Antonio Costanzo, Andrea Chiricozzi, Carlotta Gurioli, Caterina Foti, Concetta Potenza, Silvia M Ferrucci, Anna Balato, Aurora Parodi, Angelo Valerio Marzano, Michela Ortoncelli, Simone Ribero, Pietro Quaglino
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Nicole Macagno, Luca Mastorino, Niccolò Siliquini, Umberto Santaniello, Federica Gelato, Giovanni Cavaliere, Michela Ortoncelli, Simone Ribero, Pietro Quaglino
Safety of dupilumab in patients with cancer. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Luca Mastorino, Richard Borrelli, Nicole Macagno, Federica Gelato, Erica Baima, Irene Richiardi, Giovanni Cavaliere, Pietro Quaglino, Michela Ortoncelli, Simone Ribero
Therapeutic Modulation of Dupilumab in Patients with Severe Atopic Dermatitis: Clinical Effectiveness in Real Life. Dermatitis : contact, atopic, occupational, drug (2024)
Luca Mastorino, Paolo Dapavo, Caterina Cariti, Sara Susca, Niccolò Siliquini, Michela Ortoncelli, Elena Stroppiana, Anna Verrone, Isotta Giunipero di Corteranzo, Francesco Leo, Pietro Quaglino, Simone Ribero
Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience. Journal of personalized medicine 14 (7) (2024)
Luca Mastorino, Paolo Dapavo, Lorenza Burzi, Francois Rosset, Isotta Giunipero di Corteranzo, Francesco Leo, Anna Verrone, Elena Stroppiana, Michela Ortoncelli, Simone Ribero, Pietro Quaglino
Drug survival, effectiveness, and safety of brodalumab for moderate-to-severe psoriasis up to 3 years. International journal of dermatology 63 (7) (2024)
Luca Mastorino, Paolo Dapavo, Caterina Cariti, Sara Susca, Niccolò Siliquini, Michela Ortoncelli, Elena Stroppiana, Anna Verrone, Isotta Giunipero di Corteranzo, Francesco Leo, Pietro Quaglino, Simone Ribero
Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience. Journal of personalized medicine 14 (7) (2024)
Gianluca Avallone, Francesco Cavallo, Annalisa Tancredi, Carlo Alberto Maronese, Martina Bertello, Alessandro Fraghì, Conforti Claudio, Giulia Calabrese, Matteo R Di Nicola, Giorgio A Oddenino, Luigi Gargiulo, Niccolò Gori, Camilla Loi, Paolo Romita, Viviana Piras, Laura Bonzano, Ersilia Tolino, Giovanni Paolino, Maddalena Napolitano, Cataldo Patruno, Eustachio Nettis, Caterina Ferreli, Gabriele Roccuzzo, Luca Marozio, Martina Silvio, Filomena Russo, Luca Bettolini, Rosella Gallo, Santo R Mercuri, Luca Mastorino, Mariateresa Rossi, Iris Zalaudek, Giuseppe Argenziano, Ilaria Trave, Antonio Costanzo, Andrea Chiricozzi, Carlotta Gurioli, Caterina Foti, Concetta Potenza, Silvia M Ferrucci, Anna Balato, Aurora Parodi, Angelo Valerio Marzano, Michela Ortoncelli, Simone Ribero, Pietro Quaglino
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Riccardo Viola, Luca Mastorino, Matteo Megna, Giovanni Damiani, Paolo Gisondi, Giuseppe Argenziano, Ketty Peris, Francesca Prignano, Martina Burlando, Andrea Conti, Francesco Loconsole, Piergiorgio Malagoli, Iris Zalaudek, Sara Cacciapuoti, Francesco Bellinato, Anna Balato, Clara De Simone, Karin Chersi, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort. International journal of dermatology 63 (3) (2024)
Luca Mastorino, Rebecca Daniele, Paolo Dapavo, Giada Frigatti, Renata Ponti, Isotta Giunipero di Corteranzo, Eleonora Bongiovanni, Pietro Quaglino, Simone Ribero
Alcohol abuse and discretionary habits in psoriatic patients: impact on IL-17 and IL-23 inhibitor response. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (2024)
Riccardo Viola, Luca Mastorino, Matteo Megna, Giovanni Damiani, Paolo Gisondi, Giuseppe Argenziano, Ketty Peris, Francesca Prignano, Martina Burlando, Andrea Conti, Francesco Loconsole, Piergiorgio Malagoli, Iris Zalaudek, Sara Cacciapuoti, Francesco Bellinato, Anna Balato, Clara De Simone, Karin Chersi, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort. International journal of dermatology 63 (3) (2024)
Luca Mastorino, F Gelato, P Quaglino, M Ortoncelli, Simone Ribero
Efficacy of tralokinumab after failure with upadacitinib and dupilumab in a patient affected by atopic dermatitis. The Journal of dermatological treatment 34 (1) (2023)
Luca Mastorino, Federica Gelato, Irene Richiardi, Giovanni Cavaliere, Pietro Quaglino, Michela Ortoncelli, Simone Ribero
Dose reduction of dupilumab in atopic patients with controlled atopic dermatitis: A safe and effective practice? Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luca Mastorino, P Dapavo, Lorenza Burzi, F Rosset, I Giunipero di Corteranzo, F Leo, A Verrone, E Stroppiana, M Ortoncelli, Simone Ribero, Pietro Quaglino
Drug survival, effectiveness and safety of ixekizumab for moderate-to-severe psoriasis up to 5 years. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (3) (2023)
Francois Rosset, Luca Mastorino, P Dapavo, Pietro Quaglino, Simone Ribero
Impact of comorbidities in elderly and frail patients and response to biological therapy in psoriasis. Experimental dermatology (2023)
Alessia Andrea Ricci, Paolo Dapavo, Luca Mastorino, Gabriele Roccuzzo, Samanta Wolff, Simone Ribero, Paola Cassoni, Rebecca Senetta, Pietro Quaglino
Exploring Psoriasis Inflammatory Microenvironment by NanoString Technologies. Journal of clinical medicine 12 (21) (2023)
Luca Mastorino, F Gelato, P Quaglino, M Ortoncelli, Simone Ribero
Efficacy of tralokinumab after failure with upadacitinib and dupilumab in a patient affected by atopic dermatitis. The Journal of dermatological treatment 34 (1) (2023)
Gianluca Avallone, Carlo Alberto Maronese, Giulia Murgia, Carlo Giovanni Carrera, Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Silvia Alberti Violetti, Pietro Quaglino, Simone Ribero, Angelo Valerio Marzano
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study. Journal of clinical medicine 12 (4) (2023)
Michela Ortoncelli, Luca Mastorino, Federica Gelato, Irene Richiardi, Giovanni Cavaliere, Pietro Quaglino, Simone Ribero
Herpes Zoster Infection in Atopic Patients Undergoing Upadacitinib: Practical Suggestions on Vaccination and Management. Dermatitis : contact, atopic, occupational, drug (2023)
Luca Mastorino, P Dapavo, Lorenza Burzi, F Rosset, I Giunipero di Corteranzo, F Leo, A Verrone, E Stroppiana, M Ortoncelli, Simone Ribero, Pietro Quaglino
Drug survival, effectiveness and safety of ixekizumab for moderate-to-severe psoriasis up to 5 years. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Francois Rosset, Luca Mastorino, Paolo Dapavo, Michela Ortoncelli, Pietro Quaglino, Simone Ribero
Aging Impact in Response to Different Classes of Biological Treatment in Psoriatic Patients: A Real-Life Observational Study. Journal of clinical medicine 12 (23) (2023)
Nadia Sciamarrelli, Niccolò Siliquini, Luca Mastorino, Rebecca Senetta, Paolo Dapavo, Simone Ribero, Pietro Quaglino
Exacerbation of acquired perforating dermatosis following SARS-CoV-2 vaccination. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luca Mastorino, F Gelato, I Richiardi, G Cavaliere, Pietro Quaglino, M Ortoncelli, Simone Ribero
Dose reduction of dupilumab in atopic patients with controlled atopic dermatitis: a safe and effective practice? Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Nadia Sciamarrelli, Niccolò Siliquini, Luca Mastorino, Rebecca Senetta, Paolo Dapavo, Simone Ribero, Pietro Quaglino
Exacerbation of Acquired Perforating Dermatosis Following SARS-CoV-2 Vaccination. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luca Mastorino, M Ortoncelli, P Dapavo, Simone Ribero, Pietro Quaglino
'Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients'-response to Yu et al. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Silvia Giordano, Paolo Dapavo, Michela Ortoncelli, Elena Stroppiana, Anna Verrone, Pietro Quaglino, Simone Ribero, Luca Mastorino
Interclass Switch between IL17 and IL23 Inhibitors in Psoriasis: A Real-Life, Long-Term, Single-Center Experience. Journal of clinical medicine 12 (24) (2023)
Luca Mastorino, P Dapavo, Lorenza Burzi, F Rosset, I Giunipero di Corteranzo, F Leo, A Verrone, E Stroppiana, M Ortoncelli, Simone Ribero, Pietro Quaglino
Drug survival, effectiveness and safety of ixekizumab for moderate-to-severe psoriasis up to 5 years. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (3) (2023)
Valentina Celoria, Francois Rosset, Valentina Pala, Paolo Dapavo, Simone Ribero, Pietro Quaglino, Luca Mastorino
The Skin Microbiome and Its Role in Psoriasis: A Review. Psoriasis (Auckland, N.Z.) 13 (2023)
Gianluca Avallone, Carlo Alberto Maronese, Giulia Murgia, Carlo Giovanni Carrera, Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Silvia Alberti Violetti, Pietro Quaglino, Simone Ribero, Angelo Valerio Marzano
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study. Journal of clinical medicine 12 (4) (2023)
Gianluca Avallone, Carlo Alberto Maronese, Giulia Murgia, Carlo Giovanni Carrera, Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Silvia Alberti Violetti, Pietro Quaglino, Simone Ribero, Angelo Valerio Marzano
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study. Journal of clinical medicine 12 (4) (2023)
Luca Mastorino, Caterina Cariti, Sara Susca, Niccolò Siliquini, Anna Verrone, Elena Stroppiana, Michela Ortoncelli, Paolo Dapavo, Pietro Quaglino, Simone Ribero
Comparison between brodalumab, secukinumab and ixekizumab effectiveness and drug survival: A real-life experience on 638 patients with psoriasis. Experimental dermatology (2023)
Luca Mastorino, S Susca, C Cariti, Niccolò Siliquini, A Verrone, E Stroppiana, M Ortoncelli, P Dapavo, Simone Ribero, Pietro Quaglino
Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Silvia Giordano, Paolo Dapavo, Michela Ortoncelli, Elena Stroppiana, Anna Verrone, Pietro Quaglino, Simone Ribero, Luca Mastorino
Interclass Switch between IL17 and IL23 Inhibitors in Psoriasis: A Real-Life, Long-Term, Single-Center Experience. Journal of clinical medicine 12 (24) (2023)
Valentina Pala, Simone Ribero, Pietro Quaglino, Luca Mastorino
Updates on Potential Therapeutic Approaches for Vitiligo: Janus Kinase Inhibitors and Biologics. Journal of clinical medicine 12 (23) (2023)
Gianluca Avallone, Carlo Alberto Maronese, Giulia Murgia, Carlo Giovanni Carrera, Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Silvia Alberti Violetti, Pietro Quaglino, Simone Ribero, Angelo Valerio Marzano
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study. Journal of clinical medicine 12 (4) (2023)
Luca Mastorino, S Susca, C Cariti, N Sliquini, A Verrone, E Stroppiana, M Ortoncelli, P Dapavo, Simone Ribero, Pietro Quaglino
Efficacy of anti IL23 and anti IL17 after adalimumab failure in psoriatic patients. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Niccolò Siliquini, Gianluca Avallone, Marco Rubatto, Pietro Quaglino, Simone Ribero
Switching from IL23 inhibitors to IL17 inhibitors: A safe and effective practice? Dermatologic therapy 35 (9) (2022)
Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Niccolò Siliquini, Gianluca Avallone, Marco Rubatto, Martina Merli, Andrea Agostini, Simone Ribero, Pietro Quaglino
Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population. The British journal of dermatology 187 (2) (2022)
Marco Rubatto, Federica Gelato, Luca Mastorino, Silvia Giordano, Simone Ribero, Pietro Quaglino
Nonmelanoma skin cancer arising on tattoos. International journal of dermatology (2022)
Giuseppe Gallo, Luca Mastorino, Luca Tonella, Simone Ribero, Pietro Quaglino
Alopecia areata after COVID-19 vaccination. Clinical and experimental vaccine research 11 (1) (2022)
Giuseppe Gallo, Luca Mastorino, Diego Barilà, Francesco Cattel, Michele Panzone, Pietro Quaglino, Simone Ribero, Paolo Dapavo
Topical cyclosporine hydrogel preparation: A new therapeutic option in the treatment of nail psoriasis. Dermatologic therapy (2022)
Luca Mastorino, C Cariti, S Susca, S Boskovic, C Aquino, M Ortoncelli, E Stroppiana, A Verrone, P Dapavo, P Quaglino, Simone Ribero
Brodalumab efficacy in bio-naïve psoriasis patients: real-life experience of 202 subjects up to 48 weeks. The Journal of dermatological treatment (2022)
Luca Mastorino, V L Cantafio Duò, C Vecco, F Gelato, S Giordano, G Roccuzzo, G Cavaliere, G Avallone, M Ortoncelli, Simone Ribero, Pietro Quaglino
Impact of comorbidities in the response of atopic patients treated with dupilumab: a real-life study up to 36 weeks. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (12) (2022)
Luca Mastorino, F Castelli, E Stroppiana, A Verrone, M Ortoncelli, S Susca, S Boskovic, S G Passerini, Nicole Macagno, C Cariti, M Licciardello, C Solaroli, G Pertusi, M G Aragone, G Baggini, C Addese, C Leporati, R Peila, M T Giura, G Rossotto, P Pella, L Mocci, G Merlo, R Tiberio, F Graziola, Pietro Quaglino, P Dapavo, Simone Ribero
Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patients. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (10) (2022)
Luca Mastorino, Sara Susca, Matteo Megna, Niccolò Siliquini, Pietro Quaglino, Michela Ortoncelli, Gianluca Avallone, Marco Rubatto, Gabriella Fabbrocini, Paolo Dapavo, Simone Ribero
Risankizumab shows high efficacy and maintenance in improvement of response until week 52. Dermatologic therapy 35 (5) (2022)
Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Mattia Zenone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
Guselkumab shows high efficacy and maintenance in the improvement of response until week 48, a real-life study. Dermatologic therapy 35 (10) (2022)
Luca Mastorino, S Susca, C Cariti, A Verrone, E Stroppiana, M Ortoncelli, P Dapavo, Simone Ribero, Pietro Quaglino
"Superresponders" at biologic treatment for psoriasis: a comparative study among IL17 and Il23 inhibitors. Experimental dermatology (2022)
Gianluca Avallone, C Cariti, P Dapavo, M Ortoncelli, L Conforto, Luca Mastorino, Gabriele Roccuzzo, Francesco Cavallo, Marco Rubatto, Pietro Quaglino, Simone Ribero
Real-life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (7) (2022)
Nicole Macagno, Luca Mastorino, Marco Rubatto, G Avallone, M Merli, Andrea Agostini, P Fava, Simone Ribero, Pietro Quaglino
Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (12) (2022)
Federica Gelato, Luca Mastorino, Paola Cavalla, Pietro Quaglino, Giovanni Cavaliere, Marco Vercellino, Chiara Bosa, Matilde Inglese, Raffaele De Palma, Michela Ortoncelli, Simone Ribero
Onset of multiple sclerosis in a patient on dupilumab therapy for atopic dermatitis: A case report. Dermatologic therapy 35 (10) (2022)
Giulia Gullo, Marco Rubatto, Paolo Fava, Matteo Brizio, Luca Tonella, Simone Ribero, Matelda Medri, Gianluca Avallone, Luca Mastorino, Maria Teresa Fierro, Ignazio Stanganelli, Pietro Quaglino
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study. Dermatologic therapy 35 (6) (2022)
Luca Mastorino, François Rosset, Federica Gelato, Michela Ortoncelli, Giovanni Cavaliere, Pietro Quaglino, Simone Ribero
Chronic Pruritus in Atopic Patients Treated with Dupilumab: Real Life Response and Related Parameters in 354 Patients. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Luca Mastorino, Sara Susca, Caterina Cariti, Anna Verrone, Elena Stroppiana, Michela Ortoncelli, Paolo Dapavo, Simone Ribero, Pietro Quaglino
"Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors. Experimental dermatology (2022)
Alessandro Nepote, Gianluca Avallone, Simone Ribero, Francesco Cavallo, Gabriele Roccuzzo, Luca Mastorino, Conforti Claudio, Luca Paruzzo, Stefano Poletto, Fabrizio Carnevale Schianca, Pietro Quaglino, Massimo Aglietta
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma. Journal of clinical medicine 11 (3) (2022)
Gianluca Avallone, Carlo Alberto Maronese, Conforti Claudio, Paolo Fava, Luigi Gargiulo, Angelo Valerio Marzano, C Massone, Luca Mastorino, Andrea Paradisi, A Pileri, Pietro Quaglino, N Rizzo, Simone Ribero, G Roccuzzo, G Tavoletti, C A Vignoli, I Zalaudek, E Berti, S Alberti-Violetti
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: a multicentre experience from tertiary referral hospitals. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Luca Mastorino, Michela Ortoncelli, Bernardi Virginia, Giovanni Rolla, Gianluca Avallone, Giovanni Cavaliere, Viola Riccardo, Pietro Quaglino, Simone Ribero
Dupilumab-induced Urticaria. Dermatologic therapy 34 (6) (2021)
Luca Tonella, Valentina Pala, Renata Ponti, Marco Rubatto, Giuseppe Gallo, Luca Mastorino, Gianluca Avallone, Martina Merli, Andrea Agostini, Paolo Fava, Luca Bertero, Rebecca Senetta, Simona Osella-Abate, Simone Ribero, Maria Teresa Fierro, Pietro Quaglino
Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications. International journal of molecular sciences 22 (9) (2021)
Luca Mastorino, Paolo Dapavo, Gianluca Avallone, Martina Merli, Caterina Cariti, Marco Rubatto, Valentina Pala, Pietro Quaglino, Simone Ribero
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden? The Journal of dermatological treatment (2021)
Luca Mastorino, Riccardo Viola, Michele Panzone, Gianluca Avallone, Giuseppe Gallo, Michela Ortoncelli, Giovanni Cavaliere, Pietro Quaglino, Simone Ribero
Dupilumab induces a rapid decrease of pruritus in adolescents: A pilot real-life study. Dermatologic therapy 34 (6) (2021)
Paolo Dapavo, Niccolò Siliquini, Luca Mastorino, Gianluca Avallone, Martina Merli, Andrea Agostini, Caterina Cariti, Riccardo Viola, Elena Stroppiana, Anna Verrone, Michela Ortoncelli, Pietro Quaglino, Simone Ribero
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study. The Journal of dermatological treatment (2021)